Net Health
Net Health is a healthcare software company that builds specialized electronic health record (EHR/EMR) and analytics solutions for specialty care settings, including wound care (its WoundExpert and Tissue Analytics products), rehabilitation therapy, occupational health, and value-based care. The company says its software is used across more than 25,000 facilities in the United States. It is headquartered in Pittsburgh, Pennsylvania.
Company profile compiled from public sources (company filings, rating-agency reports, and press releases) — distinct from the SEC Schedule-of-Investments pricing data below.
Lenders
SEC filing entity: Net Health Acquisition Corp.
Net Health is held by 2 BDC lenders in our parsed SEC filings: CCAP, GBDC.
Cross-lender loan pricing
Each row is one debt tranche at the BDC’s most recent filing that holds this borrower, widest spread first. Mark is the position’s fair value as a percent of par (100 = par). Spread is shown in basis points over the benchmark in the Rate column, normalized from each filing’s as-reported units — rows quoting different benchmarks are still not directly comparable. Compare like-for-like: a second-lien tranche, a different vintage, or an older filing should price wider even when the credit view is identical — check the Type and Filing columns before reading a gap as disagreement. Source: SEC EDGAR (public). Rows marked stale are from an earlier filing than the lender’s latest — the borrower is absent from its newest filing (exited, repaid, or reported under a different name).
| BDC | Type | Rate | Cash spread (bps) | Mark (% of par) | Fair Value | Maturity | Filing |
|---|---|---|---|---|---|---|---|
| CCAP | 1L Sr Secured | SOFR | 475 | 100.0 | $13M | 2031-07-31 | 2026-08-10 |
| CCAP | 1L Sr Secured | FIXED | — | — | — | 2031-07-31 | 2026-08-10 |
| GBDC | 1L Sr Secured | SOFR | 575 | 100.0 | $313K | 2025-12 | 2024-08-05 stale |
| GBDC | 1L Sr Secured | SOFR | 575 | 100.0 | $5M | 2025-12 | 2024-08-05 stale |
| GBDC | 1L Sr Secured | SOFR | 575 | 100.0 | $1M | 2025-12 | 2024-08-05 stale |
| GBDC | 1L Sr Secured | SOFR | 575 | 100.0 | $14M | 2025-12 | 2024-08-05 stale |
| GBDC | 1L Sr Secured | SOFR | 575 | 100.0 | $9M | 2025-12 | 2024-08-05 stale |
| GBDC | 1L Sr Secured | SOFR | 575 | 100.0 | $7M | 2025-12 | 2024-08-05 stale |
Marks reflect each BDC’s own fair-value estimates as reported to the SEC, not traded prices. Private-credit loans are predominantly Level 3 under ASC 820 — valued from unobservable inputs and determined in good faith by each BDC’s board, so figures are estimates as of the filing date and are not directly comparable across managers. Informational only; not investment advice or a valuation.
Ownership & deal activity
Headlines mentioning Net Health
Reading this table
When two business development companies lend to the same borrower, comparing how each marks the loan is a starting question, not a verdict. In plain English: a wider spread (e.g. S+575 vs S+525) or a lower mark (e.g. 96 vs 100 cents on the dollar) can mean that lender is pricing in more risk — but marks can also differ for reasons other than a credit view: a different tranche (second lien should price wider than first lien on the same company), a different vintage or entry point, an older filing date, or each manager’s own fair-value methodology. Compare like-for-like — check the Type and Filing columns before reading a gap as disagreement. Each row is one debt position at one BDC’s most recent filing. Source: SEC EDGAR Schedule of Investments (public).
Want to read these numbers like an analyst? Free Oxford Ledge lessons: reading a BDC’s Schedule of Investments, key credit metrics, and the Five Cs of credit analysis.